1. AB0772 EFFICACY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH SELF-REPORTED PSORIATIC ARTHRITIS WITH INVOLVEMENT OF THE SCALP, NAILS, HANDS, AND FEET: A POOLED ANALYSIS FROM 2 PIVOTAL PHASE 3 PSORIASIS STUDIES. (June 2019) Authors: Merola, Joseph F.; Chakravarty, Soumya D.; You, Yin; Kafka, Shelly; Karyekar, Chetan; Orbai, Ana-Maria Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An ensemble learning based framework to estimate warfarin maintenance dose with cross-over variables exploration on incomplete data set. (April 2021) Authors: Liu, Yan; Chen, Jihui; You, Yin; Xu, Ajing; Li, Ping; Wang, Yu; Sun, Jiaxing; Yu, Ze; Gao, Fei; Zhang, Jian Journal: Computers in biology and medicine Issue: Volume 131(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2. (4th July 2021) Authors: Puig, Luis; Wu, Jashin J.; Gooderham, Melinda J.; You, Yin; Shen, Yaung-Kaung; Randazzo, Bruce; Kerdel, Francisco Journal: Journal of dermatological treatment Issue: Volume 32:Number 5(2021) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1. (17th February 2022) Authors: Griffiths, Christopher E. M.; Papp, Kim A.; Song, Michael; Miller, Megan; You, Yin; Shen, Yaung-Kaung; Han, Chenglong; Blauvelt, Andrew Journal: Journal of dermatological treatment Issue: Volume 33:Number 2(2022) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Correlation of Physician-Assessed Psoriasis Area and Severity Index Scores With Patient-Reported Psoriasis Symptoms and Signs Diary Scores Among Patients With Moderate-to-Severe Psoriasis: Results From VOYAGE 1 and VOYAGE 2 Studies. Issue 3 (July 2019) Authors: Gordon, Kenneth B.; Han, Chenglong; Li, Shu; You, Yin; Song, Michael; Fakharzadeh, Steven; Crowley, Jeffrey J.; Reich, Kristian Journal: Journal of psoriasis and psoriatic arthritis Issue: Volume 4:Issue 3(2019) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. Issue 1 (10th February 2020) Authors: Helliwell, Philip S; Gladman, Dafna D; Chakravarty, Soumya D; Kafka, Shelly; Karyekar, Chetan S; You, Yin; Campbell, Kim; Sweet, Kristen; Kavanaugh, Arthur; Gensler, Lianne S Journal: RMD open Issue: Volume 6:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Issue 11 (20th November 2016) Authors: Kavanaugh, Arthur; Puig, Lluis; Gottlieb, Alice B; Ritchlin, Christopher; You, Yin; Li, Shu; Song, Michael; Randazzo, Bruce; Rahman, Proton; McInnes, Iain B Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 11(2016) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Issue 11 (20th April 2016) Authors: Kavanaugh, Arthur; Puig, Lluis; Gottlieb, Alice B; Ritchlin, Christopher; You, Yin; Li, Shu; Song, Michael; Randazzo, Bruce; Rahman, Proton; McInnes, Iain B Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 11(2016) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. (19th May 2022) Authors: Blauvelt, Andrew; Armstrong, April W.; Langley, Richard G.; Gebauer, Kurt; Thaçi, Diamant; Bagel, Jerry; Guenther, Lyn C.; Paul, Carle; Randazzo, Bruce; Flavin, Susan; Hsu, Ming-Chun; You, Yin; Reich, Kristian Journal: Journal of dermatological treatment Issue: Volume 33:Number 4(2022) Page Start: 2317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2. Issue 2 (18th August 2019) Authors: McInnes, Iain B; Chakravarty, Soumya D; Apaolaza, Isabel; Kafka, Shelly; Hsia, Elizabeth C; You, Yin; Kavanaugh, Arthur Journal: RMD open Issue: Volume 5:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗